Strong BOB1 and OCT2 Expression Is Useful for Confirming B-Cell Lineage in PEL and Other Neoplasms with Plasmacytic/Plasmablastic Differentiation

被引：0
|
作者：
Chen, C. K. [1 ]
Mo, Z. [1 ]
Moschiao, E. [1 ]
Schmidt, M. [1 ]
Alkan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1353
引用
收藏
页码：324A / 324A
页数：1
相关论文
共 11 条
  • [1] Strong BOB1 and OCT2 Expression Is Useful for Confirming B-Cell Lineage in PEL and Other Neoplasms with Plasmacytic/Plasmablastic Differentiation
    Chen, C. K.
    Mo, Z.
    Moschiao, E.
    Schmidt, M.
    Alkan, S.
    LABORATORY INVESTIGATION, 2013, 93 : 324A - 324A
  • [2] Bob1 and Oct2 Expression in Lineage Determination of B-Cell Lymphomas Negative for Conventional B-Cell Markers
    Yin, L.
    Xu, J.
    Li, M.
    Reddy, V.
    Zhou, Q.
    Liu, H.
    Chu, P.
    Zhang, Q.
    Huang, Q.
    Gao, Z.
    Wang, H-Y
    Liang, X.
    Pan, Z.
    MODERN PATHOLOGY, 2013, 26 : 369A - 369A
  • [3] Bob1 and Oct2 Expression in Lineage Determination of B-Cell Lymphomas Negative for Conventional B-Cell Markers
    Yin, L.
    Xu, J.
    Li, M.
    Reddy, V.
    Zhou, Q.
    Liu, H.
    Chu, P.
    Zhang, Q.
    Huang, Q.
    Gao, Z.
    Wang, H-Y
    Liang, X.
    Pan, Z.
    LABORATORY INVESTIGATION, 2013, 93 : 369A - 369A
  • [4] Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers
    Yin, Liqun
    Xu, Jie
    Li, Min
    Reddy, Vishnu
    Zhou, Quan
    Liu, Huanxin
    Chu, Peiguo
    Zhang, Qianyun
    Huang, Qin
    Gao, Zifen
    Liang, Xiayuan
    Wang, Huan-You
    Pan, Zenggang
    HISTOPATHOLOGY, 2016, 69 (05) : 775 - 783
  • [5] Differential Eμ enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas
    Loddenkemper, C
    Anagnostopoulos, L
    Hummel, M
    Johrens-Leder, K
    Foss, HD
    Jundt, F
    Wirth, T
    Dörken, B
    Stein, H
    JOURNAL OF PATHOLOGY, 2004, 202 (01): : 60 - 69
  • [6] Expression of Oct2 and BOB.1 in Hodgkin lymphoma (HL), diffuse large B cell lymphoma (DLBCL) and anaplastic large cell lymphoma (ALC)
    Prabhu, VR
    Ashton-Key, M
    JOURNAL OF PATHOLOGY, 2005, 207 : 51 - 51
  • [7] B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma
    Herbeck, Rosemarie
    Brinzeu, D. Teodorescu
    Giubelan, Marioara
    Lazar, Elena
    Dema, Alis
    Ionita, Hortensia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (01): : 69 - 74
  • [8] Differential expression of OCT-2, BOB-1 and Pax-5 in diffuse large B-cell lymphoma (DLBCL) subtypes using tissue microarray in a Saudi Arabian cohort
    Al Othman, S
    Attanoos, R
    Poynton, C
    Dojcinov, S
    ANNALS OF ONCOLOGY, 2005, 16 : 75 - 75
  • [9] The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma
    Browne, P
    Petrosyan, K
    Hernandez, A
    Chan, JA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (05) : 767 - 777
  • [10] Primary mediastinal B-cell lymphoma - High frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins
    Pileri, SA
    Gaidano, G
    Zinzani, PL
    Falini, B
    Gaulard, P
    Zucca, E
    Pieri, F
    Berra, E
    Sabattini, E
    Ascani, S
    Piccioli, M
    Johnson, PWM
    Giardini, R
    Pescarmona, E
    Novero, D
    Piccaluga, PP
    Marafioti, T
    Alonso, MA
    Cavalli, F
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01): : 243 - 253
12